Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants

Context: It has been reported that isoprostanes (IPs) have a role in the pathophysiology of ductus arteriosus during the fetal and neonatal period. Our aim in this study was to assess if urinary IPs (uIPs) levels correlate with the risk of developing a hemodynamically significant patent ductus arter...

Descripción completa

Detalles Bibliográficos
Autores principales: Coviello, Caterina, Tataranno, Maria Luisa, Corsini, Iuri, Leonardi, Valentina, Longini, Mariangela, Bazzini, Francesco, Buonocore, Giuseppe, Dani, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506157/
https://www.ncbi.nlm.nih.gov/pubmed/33014939
http://dx.doi.org/10.3389/fped.2020.00555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506157/
https://www.ncbi.nlm.nih.gov/pubmed/33014939
http://dx.doi.org/10.3389/fped.2020.00555

Ejemplares similares